Sun Pharma's recent FDA approval of original drug treatment Ilumya (a psoriasis drug) has given it a boost in stock markets, as analysts are bullish of its annual year performance. The stock has been gaining in share price and it currently tops the SMA breakout screener, with its share price crossing over its SMA 200 today. Cera Sanitaryware and Transport Corporation of India also saw positive breakouts today. For the full screener click here.
